Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD.

Related Content:

• Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.

Related Content:

• Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy

Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD.

Related Content:

• Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

Interview with Gretchen L. Gierach, PhD, author of Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting

Interview with Conny Vrieling, MD PhD, author of Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

Interview with Razelle Kurzrock, MD, author of Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis

Interview with Smita Bhatia, MD, MPH, author of Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study

Interview with Mingyang Song, MD, ScD, author of Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among Whites in the United States

Interview with Ahmad Awada, MD, PhD, author of Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial, and Mark D. Pegram, MD, author of Neratinib in ERBB2-Positive Brain Metastases

Interview with Ruth Etzioni, PhD, author of Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies, and Andrew J. Vickers, PhD, author of Does Prostate-Specific Antigen Screening Do More Good Than Harm? Depends on How You Do It

Interview with Andrew T. Chan, MD, MPH, author of Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer

Interview with Ann H. Partridge, MD, MPH, author of BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer

Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD.

Related Content:

• Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

Interview with Katherine A. Janeway, MD, MSc, author of Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study, and D. Williams Parsons, MD, PhD, author of Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

Interview with Mariana Chavez-MacGregor, MD, MSc, author of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer, and Richard J. Bleicher, MD, author of Time to Surgery and Breast Cancer Survival in the United States

Interview with William N. William Jr, MD, and Scott M. Lippman, MD, author of Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial

Interview with Diana L. Miglioretti, PhD, author of Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status

Interview with Ola Landgren, MD, PhD, author of Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study, and Nikhil C. Munshi, MD, author of Association of Agent Orange With Plasma Cell Disorder: Further Evidence

Interview with Reshma Jagsi, MD, DPhil, author of Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort, and Benjamin D. Smith, MD, author of Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial

Interview with Amol K. Narang, MD, author of Trends in Advance Care Planning in Patients With Cancer: Results From a National Longitudinal Survey, and Michael J. Fisch, MD, author of Advance Directives: Sometimes Necessary But Rarely Sufficient

Interview with Marian L. Neuhouser, PhD, RD, author of Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials, and Clifford Hudis, MD, author of Obesity and Breast Cancer: Narrowing the Focus

Interview with Christopher Murray, DPhil, MD and Christina Fitzmaurice, MD, MPH, authors of The Global Burden of Cancer 2013

Interview with Emile E. Voest, MD, PhD, author of Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil

Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD.

Related Content:

• Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

Interview with Michaela A. Dinan, PhD, author of Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009

Interview with David Huntsman, MD and Samantha Hansford, BSc, authors of Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond

Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD.

Related Content:

• Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer

Interview with Daniel E. Spratt, MD, author of Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer. Hosted by Jack West, MD.

Related Content:

• Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer

Interview with Oreste Davide Gentilini, MD, author of Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. Hosted by Jack West, MD.

Related Content:

• Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes

Interview with Kara N. Goldman, MD, author of A Geospatial Analysis of Disparities in Access to Oncofertility Services. Hosted by Jack West, MD.

Related Content:

• A Geospatial Analysis of Disparities in Access to Oncofertility Services

Interview with Sean P. Pitroda, MD, author of Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. Hosted by Jack West, MD.

Related Content:

• Integrated Clinical-Molecular Classification of Colorectal Liver Metastases

Interview with Sophia C. Kamran, MD, author of US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020. Hosted by Jack West, MD.

Related Content:

• US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020

Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD.

Related Content:

• Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

Interview with Katrina A. B. Goddard, PhD, author of Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. Hosted by Vivek Subbiah, MD.

Related Content:

• Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Interview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. Hosted by Jack West, MD.

Related Content:

• Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine

Interview with Dian Wang, MD, author of Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. Hosted by Jack West, MD.

Related Content:

• Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy

Interview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. Hosted by Jack West, MD.

Related Content:

• Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

Interview with Nancy L. Keating, MD, MPH, author of Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy. Hosted by Jack West, MD.

Related Content:

• Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy

Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD.

Related Content:

• Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD.

Related Content:

• Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD.

Related Content:

• Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD.

Related Content:

• Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities

Interview with Hagen F. Kennecke, MD, author of Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy. Hosted by Jack West, MD.

Interview with Paolo Boffetta, MD, author of Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis. Hosted by Jack West, MD.

Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

• Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science.

Related Content:

• The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network
• A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (video)
• A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (audio)

Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.

Interview with Lars Björnebo, MSc, and Anna Lantz, MD, PhD, authors of Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. Hosted by Jack West, MD.

Interview with David Anthony Palma, MD, PhD, and Anthony C. Nichols, MD, authors of Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial

Hosted by Jack West, MD.